MTOR mutations are common in malignant tumors, such as endometrial carcinoma, melanoma, esophagogastric adenocarcinoma, colorectal adenocarcinoma, renal cell carcinoma, and bladder cancer (Table 2) (29). Here, MTOR is linked to endometrial carcinoma.